During the past decade, Sutter Pacific Medical Foundation conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 67 clinical trials were completed, i.e. on average, 98.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 50 clinical trials were completed. i.e. 416.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sutter Pacific Medical Foundation" #1 sponsor was "National Cancer Institute (NCI)" with 59 trials, followed by "SWOG Cancer Research Network" with 28 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "GOG Foundation" with 8 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter Pacific Medical Foundation" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Sutter Pacific Medical Foundation" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (6 trials) and "Invasive Breast Carcinoma" (6 trials). Many other conditions were trialed in "Sutter Pacific Medical Foundation" in a lesser frequency.

Most popular intervention types in "Sutter Pacific Medical Foundation" are "Drug" (100 trials), "Other" (77 trials), "Biological" (51 trials), "Procedure" (26 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (49 trials), "Quality-of-Life Assessment" (23 trials), "Carboplatin" (15 trials), "Computed Tomography" (15 trials) and "Paclitaxel" (15 trials). Other intervention names were less common.

The vast majority of trials in "Sutter Pacific Medical Foundation" are 89 trials for "All" genders, 28 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Sutter Pacific Medical Foundation". undefined are not yet recruiting, 17 are recruiting, 63 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Sutter Pacific Medical Foundation, 2 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Sutter Pacific Medical Foundation, 3 "Phase 1" clinical trials were conducted, 66 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".